CATABASIS PHARMACEUTICALS IN's ticker is and the CUSIP is 14875P206. A total of 30 filers reported holding CATABASIS PHARMACEUTICALS IN in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $130,000 | -9.7% | 61,444 | +23.4% | 0.00% | – |
| Q1 2021 | $144,000 | +14.3% | 49,798 | -15.3% | 0.00% | – |
| Q4 2020 | $126,000 | -92.2% | 58,827 | -77.5% | 0.00% | -100.0% |
| Q3 2020 | $1,617,000 | -1.5% | 261,221 | +2.4% | 0.00% | 0.0% |
| Q2 2020 | $1,641,000 | +60.7% | 255,167 | +3.7% | 0.00% | 0.0% |
| Q1 2020 | $1,021,000 | -26.9% | 245,974 | +4.1% | 0.00% | 0.0% |
| Q4 2019 | $1,397,000 | +14.9% | 236,374 | +4.9% | 0.00% | – |
| Q3 2019 | $1,216,000 | -31.1% | 225,261 | +3.0% | 0.00% | -100.0% |
| Q2 2019 | $1,765,000 | +50.3% | 218,651 | +47.5% | 0.00% | – |
| Q1 2019 | $1,174,000 | – | 148,213 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 300,000 | $2,421,000 | 1.60% |
| SV Health Investors, LLC | 285,765 | $2,306,000 | 1.55% |
| Alyeska Investment Group, L.P. | 1,125,000 | $9,079,000 | 0.12% |
| FEDERATED HERMES, INC. | 2,189,400 | $17,668,000 | 0.04% |
| OXFORD ASSET MANAGEMENT LLP | 139,451 | $1,125,000 | 0.02% |
| OPPENHEIMER & CO INC | 68,706 | $554,000 | 0.02% |
| RMB Capital Management, LLC | 60,618 | $489,000 | 0.01% |
| Blackstone Inc. | 200,819 | $1,621,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 20,900 | $169,000 | 0.00% |
| DIMENSIONAL FUND ADVISORS LP | 218,651 | $1,765,000 | 0.00% |